FDA Inspection
The Stamford HospitalThe Stamford Hospital – FDA Inspection, Mar 2, 2026
Record Details
This FDA Inspection record concerns The Stamford Hospital, with an inspection on March 2, 2026, issued by the New England District Office, covering biologics.
View Company Profile
ID · 18f0da47-4cb4-40a8-abf6-5d1c44efbe88
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1305212
- FDA center
- Biologics
- Project area
- Blood and Blood Products
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 606.151(e)Procedures to maintain records of emergency transfusions
Full citation text and observation details available on the Dashboard.
Other FDA inspections of The Stamford Hospital
7| Date | Classification | Office | Project area |
|---|---|---|---|
| May 2, 2023 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| December 6, 2019 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| November 30, 2017 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| December 17, 2015 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| November 21, 2013 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for The Stamford Hospital
- FDA Inspection 1204738 - 2023-05-02
- FDA Inspection 1113858 - 2019-12-06
- FDA Inspection 1034682 - 2017-11-30
- FDA Inspection 952746 - 2015-12-17
- FDA Inspection 856333 - 2013-11-21
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.